rdf:type |
|
lifeskim:mentions |
umls-concept:C0013570,
umls-concept:C0017262,
umls-concept:C0039421,
umls-concept:C0079941,
umls-concept:C0185117,
umls-concept:C0337051,
umls-concept:C0430054,
umls-concept:C0684014,
umls-concept:C0872252,
umls-concept:C1171362,
umls-concept:C1509144,
umls-concept:C1705053,
umls-concept:C1709595,
umls-concept:C2349200,
umls-concept:C2911684
|
pubmed:issue |
11
|
pubmed:dateCreated |
2005-11-9
|
pubmed:abstractText |
We have developed a pooled ORF expression technology, POET, that uses recombinational cloning and proteomic methods (two-dimensional gel electrophoresis and mass spectrometry) to identify ORFs that when expressed are likely to yield high levels of soluble, purified protein. Because the method works on pools of ORFs, the procedures needed to subclone, express, purify, and assay protein expression for hundreds of clones are greatly simplified. Small scale expression and purification of 12 positive clones identified by POET from a pool of 688 Caenorhabditis elegans ORFs expressed in Escherichia coli yielded on average 6 times as much protein as 12 negative clones. Larger scale expression and purification of six of the positive clones yielded 47-374 mg of purified protein/liter. Using POET, pools of ORFs can be constructed, and the pools of the resulting proteins can be analyzed and manipulated to rapidly acquire information about the attributes of hundreds of proteins simultaneously.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1535-9476
|
pubmed:author |
pubmed-author:ConradsThomas PTP,
pubmed-author:EspositoDominicD,
pubmed-author:FrankPeter HPH,
pubmed-author:GilletteWilliam KWK,
pubmed-author:HaoTongT,
pubmed-author:HartleyJames LJL,
pubmed-author:HillDavid EDE,
pubmed-author:JacobowitzDavid MDM,
pubmed-author:JozwikCatherineC,
pubmed-author:McGowanBrighidB,
pubmed-author:PollardHarvey BHB,
pubmed-author:VeenstraTimothy DTD,
pubmed-author:VidalMarcM,
pubmed-author:YuLi-RongLR,
pubmed-author:ZhangXiuyingX,
pubmed-author:ZhouMingM
|
pubmed:issnType |
Print
|
pubmed:volume |
4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1647-52
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:16113400-Animals,
pubmed-meshheading:16113400-Caenorhabditis elegans,
pubmed-meshheading:16113400-Caenorhabditis elegans Proteins,
pubmed-meshheading:16113400-Cloning, Molecular,
pubmed-meshheading:16113400-Electrophoresis, Gel, Two-Dimensional,
pubmed-meshheading:16113400-Escherichia coli,
pubmed-meshheading:16113400-Gene Expression Profiling,
pubmed-meshheading:16113400-Open Reading Frames,
pubmed-meshheading:16113400-Proteome,
pubmed-meshheading:16113400-Proteomics,
pubmed-meshheading:16113400-Recombinant Fusion Proteins
|
pubmed:year |
2005
|
pubmed:articleTitle |
Pooled ORF expression technology (POET): using proteomics to screen pools of open reading frames for protein expression.
|
pubmed:affiliation |
Protein Expression Laboratory, Research Technology Program, SAIC-Frederick, Inc./NCI, National Institutes of Health, Frederick, Maryland 21702, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural,
Research Support, N.I.H., Intramural
|